Discontinued — last reported Q4 '25
Year-over-year, this metric grew by 58.1%, from $253.00M to $400.00M. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows an upward trend with a 2.8% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $206.00M | $219.00M | $0.00 | $200.00M | $200.00M | $300.00M | $150.00M | $175.00M | $175.00M | $225.00M | $225.00M | $300.00M | $300.00M | $200.00M | $207.00M | $253.00M | $308.00M | $248.00M | $0.00 | $400.00M |
| QoQ Change | — | +6.3% | -100.0% | — | +0.0% | +50.0% | -50.0% | +16.7% | +0.0% | +28.6% | +0.0% | +33.3% | +0.0% | -33.3% | +3.5% | +22.2% | +21.7% | -19.5% | -100.0% | — |
| YoY Change | — | — | — | — | -2.9% | +37.0% | — | -12.5% | -12.5% | -25.0% | +50.0% | +71.4% | +71.4% | -11.1% | -8.0% | -15.7% | +2.7% | +24.0% | -100.0% | +58.1% |